Figure 3From: Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2–mediated angiogenesisTylophorine inhibits VEGFR2 binding with VEGF and attenuated VEGFR2 tyrosine kinase activity. (A) Effect of tylophorine on the binding of VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1) to immobilized VEGF. Data were presented as means ± SEM, n = 6. **p < 0.01; ***p < 0.001 compared with control. (B) Inhibition of VEGFR2 kinase activity by tylophorine was analyzed using an in vitro HTScan® VEGF receptor 2 kinase kit (Cell Signaling Technology, Danvers, MA, USA) combined with colorimetric ELISA detection according to the manufacturer’s instructions. The reaction processed with DMSO (0.1%) served as a vehicle control. Data were expressed as percentages of the vehicle control. (C) Western blot analyses of effect of tylophorine on phosphorylation of VEGFR2. HUVECs were pre-treated with tylophorine followed by the stimulation with 50 ng/mL of VEGF for 2 min. Data were presented as means ± SEM, n = 6. (D) Quantitative densitometry of VEGFR2 phosphorylation is shown as percentage (%) of control. Data were presented as means ± SEM, n = 6. ## P < 0.01 VEGF-treated group versus no VEGF-treated group; **p < 0.01; ***p < 0.001 versus VEGF-stimulated group.Back to article page